metricas
covid
Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Prevalence and risk factors of adverse effects after the first COVID-19 booster ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Prevalencia y factores de riesgo de efectos adversos tras la primera dosis de refuerzo de COVID-19: Datos procedentes de Grecia
Petros Galanisa,
Corresponding author
pegalan@nurs.uoa.gr

Corresponding author.
, Aglaia Katsiroumpaa, Irene Vrakab, Vanessa Chrysagia, Olga Siskouc, Olympia Konstantakopouloud, Theodoros Katsoulase, Parisis Gallose, Daphne Kaitelidoud
a Clinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
b Department of Radiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
c Department of Tourism Studies, University of Piraeus, Piraeus, Greece
d Center for Health Services Management and Evaluation, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
e Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
Read
40
Times
was read the article
0
Total PDF
40
Total HTML
Share statistics
Article information
ISSN: 24451460
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 6 0 6
2024 October 1 0 1
2024 September 2 0 2
2024 August 2 0 2
2024 July 3 0 3
2024 June 8 0 8
2024 May 3 0 3
2024 April 4 0 4
2024 March 5 0 5
2024 February 3 0 3
2024 January 2 0 2
2023 December 1 0 1

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos